An assessment of vocal impairment is presented for separating healthy people from persons with early untreated Parkinson's disease (PD). This study's main purpose was to (a) determine whether voice and speech disorder are present from early stages of PD before starting dopaminergic pharmacotherapy, (b) ascertain the specific characteristics of the PD-related vocal impairment, (c) identify PD-related acoustic signatures for the major part of traditional clinically used measurement methods with respect to their automatic assessment, and (d) design new automatic measurement methods of articulation. The varied speech data were collected from 46 Czech native speakers, 23 with PD. Subsequently, 19 representative measurements were pre-selected, and Wald sequential analysis was then applied to assess the efficiency of each measure and the extent of vocal impairment of each subject. It was found that measurement of the fundamental frequency variations applied to two selected tasks was the best method for separating healthy from PD subjects. On the basis of objective acoustic measures, statistical decision-making theory, and validation from practicing speech therapists, it has been demonstrated that 78% of early untreated PD subjects indicate some form of vocal impairment. The speech defects thus uncovered differ individually in various characteristics including phonation, articulation, and prosody.

Department of Circuit Theory Faculty of Electrical Engineering Czech Technical University Prague Technicka 2 116 27 Prague 6 Czech Republic

Citace poskytuje Crossref.org

Speech impairment in a large sample of patients with multiple system atrophy: effect of gender and language

Study protocol for using a smartphone application to investigate speech biomarkers of Parkinson's disease and other synucleinopathies: SMARTSPEECH

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson's disease

Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease

Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson's disease

Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy

Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease

Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation

Automated analysis of connected speech reveals early biomarkers of Parkinson's disease in patients with rapid eye movement sleep behaviour disorder

Hypernasality associated with basal ganglia dysfunction: evidence from Parkinson's disease and Huntington's disease

Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients

Effect of dopaminergic medication on speech dysfluency in Parkinson's disease: a longitudinal study

Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy

Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication

A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse

Objective acoustic quantification of phonatory dysfunction in Huntington's disease

Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy